Register Login

Aclarion Inc (ACONW)

(99% Positive) Aclarion Inc (ACONW) Announces Enrollment Update for partnerships Due to Patient Enrollment Issues, Regulatory Process

Full text
Register to leave comments
  • News bot Jan. 31, 2026, 10:19 a.m.

    📋 Aclarion Inc (ACONW) - Clinical Trial Update

    Filing Date: 2026-01-13

    Accepted: 2026-01-13 09:00:25

    Event Type: Clinical Trial Update

    Event Details:

    Aclarion Inc (ACONW) Announces Clinical Trial Update Aclarion Inc (ACONW) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: partnerships, million
    • Diseases/Conditions: Cash BROOMFIELD, cash as of January 12
    • Collaboration: Brent Ness

    🔬 Clinical Development Pipeline (Aclarion Inc):

    Product Type Development Stage Therapeutic Area Source
    Fusion or TDR determined by investigator. PROCEDURE Preclinical Discogenic Low Back Pain ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Aclarion Inc
    • Ticker Symbol: ACONW

Search

News categories